Ardana Bioscience Ltd. Signs Agreement With Twinpharma To Market Striant™SR In The Netherlands

February 19, 2007 |

1 min read

Edinburgh, UK, 13 February 2007: Ardana plc (LSE:ARA) today announces that it has signed an agreement granting TwinPharma BV (“TwinPharma”) exclusive rights to market Striant™ SR in the Netherlands.

Alliances Europe

MORE ON THIS TOPIC

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Alltrna’s Clinical Acceleration Aims Leave 35% of Staff Behind

March 6, 2026

·

31 min read

·

BioSpace Editorial Staff

Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.

Cardiovascular disease

Alnylam Unites With Tenaya in Potential $1B+ Pact To Find New Genetic Heart Disease Targets

March 5, 2026

·

2 min read

·

Heather McKenzie

Modern design with a positive context, a handshake. Concept of help, support and harmony between adults. Modern art collage, trendy magazine style.

Collaboration

Roche Broadens Global Clinical Trial Footprint With $480M+ South Korea Pledge

March 5, 2026

·

1 min read

·

Tristan Manalac

Podcast

UniQure’s Delay, REGENXBIO’s Rejection Explained, Sarepta’s Ingram Steps Down, More

March 4, 2026

·

1 min read

·

Heather McKenzie